August 29, 2014 4:58 PM ET

Pharmaceuticals

Company Overview of Drais Pharmaceuticals, Inc.

Executive Profile

Robert E. Desjardins M.D.

Chief Scientific Officer and Director, Drais Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 4 different industries.

See Board Relationships
----

Background

Mr. Robert E. Desjardins, MD serves as the Chief Scientific Officer of Drais Pharmaceuticals Inc. Dr. Desjardins is currently the Chief Scientific Officer as well as co-founder of Drais, Inc. He co-founded AkaRx, Inc. in 2005 and served as its Chief Executive Officer and President. He is an accomplished drug developer and has extensive clinical development as well as entrepreneurial expertise. He served as Chief Development Officer of Euro-America of Yamanouchi Group ...

Corporate Headquarters

520 US Highway 22
Bridgewater, New Jersey 08807

United States

Phone: 908-895-1200
Fax: 908-895-1201

Board Members Memberships

Co-Founder
Chief Scientific Officer and Director

Education

MD
Loyola University of Chicago

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Drais Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.